1 |
LU0942225912 |
Candriam Equities L Biotechnology, R - Capitalisation |
-9,04 % |
+19,38 % |
-0,59 |
2 |
LU0133360163 |
Candriam Equities L Biotechnology, I - Capitalisation |
-9,21 % |
+19,20 % |
-0,60 |
3 |
CH0113817123 |
Bellevue Biotech DT CHF |
-9,68 % |
+19,74 % |
-0,61 |
4 |
LU1897414568 |
Janus Henderson Horizon Biotechnology Fund IU2 USD |
-13,44 % |
+25,83 % |
-0,61 |
5 |
LU1897414485 |
Janus Henderson Horizon Biotechnology Fund H2 USD |
-13,63 % |
+25,81 % |
-0,62 |
|
32 |
LU0069152568 |
UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD |
-14,59 % |
+20,77 % |
-0,81 |
|
73 |
LU0767968745 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating |
-11,60 % |
+11,31 % |
-1,23 |
74 |
LU0415392835 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating |
-15,14 % |
+13,55 % |
-1,29 |
75 |
DE000A3DCA95 |
BIT Biotech Opportunities S |
-38,46 % |
+30,62 % |
-1,33 |
76 |
LU0415392595 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating |
-15,73 % |
+13,55 % |
-1,34 |
77 |
DE000A3DCBA0 |
BIT Biotech Opportunities I-II |
-38,62 % |
+30,61 % |
-1,34 |